Refresh

AstraZeneca Pharma India Ltd. - Research Center

506820 ASTRAZEN Group (A) BSE data
Back to Company

Results

Statement

More

Annual results in brief
(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Sales

1,295.53 1,002.97 805.60 813.56 831.81

Operating profit

184.45 165.13 86.17 135.47 120.69

Interest

1.20 0.63 0.95 1.09 1.14

Gross profit

218.05 190.59 99.99 147.22 132.54

EPS (Rs)

64.60 39.72 24.64 37.32 28.88
Annual  results in details
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20

Other income

34.80 26.10 14.76 12.84 12.99

Stock adjustment

-33.77 -48.86 14.47 2.95 -39.21

Raw material

129.02 84.38 89.61 97.26 70.21

Power and fuel

- - - - -

Employee expenses

241.45 259.10 230.21 219.54 216.70

Excise

- - - - -

Admin and selling expenses

- - - 45.21 55.76

Research and development expenses

- - - - -

Expenses capitalised

- - - - -

Other expenses

774.37 543.22 385.14 313.14 407.66

Provisions made

- - - - -

Depreciation

14.94 16.26 16.95 20.13 18.58

Taxation

58.03 34.81 21.44 33.79 41.75

Net profit / loss

161.51 99.29 61.59 93.30 72.21

Extra ordinary item

16.43 -40.23 - - -

Prior year adjustments

- - - - -

Equity capital

5.00 5.00 5.00 5.00 5.00

Equity dividend rate

- - - - -

Agg.of non-prom. shares (Lacs)

- - - - -

Agg.of non promotoholding (%)

- - - - -

OPM (%)

14.24 16.46 10.70 16.65 14.51

GPM (%)

16.39 18.52 12.19 17.81 15.69

NPM (%)

12.14 9.65 7.51 11.29 8.55
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com